Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | MIER1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MIER1 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Mier1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MIER1 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | affects expression | ISO | Mier1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of MIER1 mRNA | CTD | PMID:22206623 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Mier1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MIER1 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MIER1 mRNA | CTD | PMID:33387578 | 2-methylcholine | affects expression | ISO | MIER1 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of MIER1 mRNA | CTD | PMID:21179406 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Mier1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of MIER1 mRNA | CTD | PMID:26251327 | 3,4-methylenedioxymethamphetamine | increases methylation | ISO | Mier1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of MIER1 promoter | CTD | PMID:26251327 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | MIER1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MIER1 mRNA | CTD | PMID:28628672 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of MIER1 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | ISO | Mier1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of MIER1 mRNA | CTD | PMID:19770486 | aflatoxin M1 | decreases expression | ISO | MIER1 (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of MIER1 mRNA | CTD | PMID:30928695 | all-trans-retinoic acid | increases expression | ISO | MIER1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of MIER1 mRNA | CTD | PMID:33167477 | aristolochic acid A | decreases expression | ISO | MIER1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of MIER1 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases expression | ISO | Mier1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MIER1 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | ISO | MIER1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MIER1 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | Mier1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of MIER1 exon and Benzo(a)pyrene results in increased methylation of MIER1 intron | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | MIER1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of MIER1 5' UTR | CTD | PMID:27901495 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MIER1 mRNA | CTD | PMID:25181051 more ... | bisphenol A | increases methylation | ISO | MIER1 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of MIER1 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | MIER1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MIER1 mRNA | CTD | PMID:28628672 | bisphenol A | decreases methylation | ISO | Mier1 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of MIER1 promoter | CTD | PMID:27312807 | caffeine | increases phosphorylation | ISO | MIER1 (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of MIER1 protein | CTD | PMID:35688186 | cyclosporin A | increases expression | ISO | MIER1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of MIER1 mRNA | CTD | PMID:25562108 | dexamethasone | multiple interactions | ISO | MIER1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MIER1 mRNA | CTD | PMID:28628672 | dicrotophos | decreases expression | ISO | MIER1 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of MIER1 mRNA | CTD | PMID:28302478 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of MIER1 mRNA | CTD | PMID:29391264 | folic acid | decreases expression | ISO | MIER1 (Homo sapiens) | 6480464 | Folic Acid results in decreased expression of MIER1 mRNA | CTD | PMID:21867686 | FR900359 | affects phosphorylation | ISO | MIER1 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of MIER1 protein | CTD | PMID:37730182 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of MIER1 gene | CTD | PMID:22079235 | geldanamycin | increases expression | ISO | MIER1 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of MIER1 mRNA | CTD | PMID:26705709 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of MIER1 mRNA | CTD | PMID:22061828 | hydrogen peroxide | affects expression | ISO | MIER1 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of MIER1 mRNA | CTD | PMID:20044591 | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of MIER1 mRNA | CTD | PMID:21396975 | indometacin | multiple interactions | ISO | MIER1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MIER1 mRNA | CTD | PMID:28628672 | methyl methanesulfonate | increases expression | ISO | MIER1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of MIER1 mRNA | CTD | PMID:23649840 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MIER1 mRNA | CTD | PMID:25729387 | pentachlorophenol | decreases expression | ISO | Mier1 (Mus musculus) | 6480464 | Pentachlorophenol results in decreased expression of MIER1 mRNA | CTD | PMID:23892564 | pentanal | decreases expression | ISO | MIER1 (Homo sapiens) | 6480464 | pentanal results in decreased expression of MIER1 mRNA | CTD | PMID:26079696 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | MIER1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of MIER1 mRNA | CTD | PMID:27153767 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Mier1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MIER1 mRNA | CTD | PMID:36331819 | pirinixic acid | decreases expression | ISO | Mier1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of MIER1 mRNA | CTD | PMID:23811191 | potassium chromate | decreases expression | ISO | MIER1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of MIER1 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | MIER1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MIER1 mRNA | CTD | PMID:22079256 | propiconazole | decreases expression | ISO | Mier1 (Mus musculus) | 6480464 | propiconazole results in decreased expression of MIER1 mRNA | CTD | PMID:21278054 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of MIER1 mRNA | CTD | PMID:22431001 | sodium arsenate | increases expression | ISO | Mier1 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of MIER1 mRNA | CTD | PMID:21795629 | sunitinib | increases expression | ISO | MIER1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of MIER1 mRNA | CTD | PMID:31533062 | testosterone | decreases expression | ISO | MIER1 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of MIER1 mRNA | CTD | PMID:33359661 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of MIER1 mRNA | CTD | PMID:34492290 | titanium dioxide | increases methylation | ISO | MIER1 (Homo sapiens) | 6480464 | titanium dioxide results in increased methylation of MIER1 promoter | CTD | PMID:34973136 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of MIER1 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MIER1 mRNA | CTD | PMID:25729387 | triptonide | affects expression | ISO | Mier1 (Mus musculus) | 6480464 | triptonide affects the expression of MIER1 mRNA | CTD | PMID:33045310 | valproic acid | decreases methylation | ISO | MIER1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of MIER1 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | MIER1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of MIER1 mRNA | CTD | PMID:23179753 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
